John M Ashton

Publication Activity (10 Years)

Years Active: 2016-2021
Publications (10 Years): 5

Top Topics

Prognostic Factors

Allogeneic Hematopoietic Stem Cell Transplantation

Top Venues

Science advances

Science (New York, N.Y.)

Nature communications

This page only lists publications with an associated author ORCID identifier.

Publications

Pearl Quijada, Michael A Trembley, Adwiteeya Misra, Jacquelyn A Myers, Cameron D Baker, Marta Perez-Hernandez Duran, Jason R Myers, Ronald A Dirkx, Ethan David Cohen, Mario Delmar, John M Ashton, Eric M Small
Coordination of endothelial cell positioning and fate specification by the epicardium. Nature communications 12 (1) (2021)
Tzu-Chieh Ho, Hye Sung Kim, Yumei Chen, Yamin Li, Mark W LaMere, Caroline Chen, Hui Wang, Jing Gong, Cal D Palumbo, John M Ashton, Hae-Won Kim, Qiaobing Xu, Michael W Becker, Kam W Leong
Scaffold-mediated CRISPR-Cas9 delivery system for acute myeloid leukemia therapy. Science advances 7 (21) (2021)
Reyad A Elbarbary, Lynne E Maquat, Jason R Myers, Peicheng Du, John M Ashton, Bin Tian
Tudor-SN-mediated endonucleolytic decay of human cell microRNAs promotes G1/S phase transition. Science (New York, N.Y.) 356 (6340) (2018)
Jodi Ram, Gabrielle Flamm, Marlene Balys, Umayal Sivagnanalingam, Paul G Rothberg, Anwar Iqbal, Jason R Myers, Anthony M Corbett, John M Ashton, Jason H Mendler
Index case of acute myeloid leukemia in a family harboring a novel CEBPA germ line mutation. Blood advances 1 (8) (2017)
Tzu-Chieh Ho, Mark LaMere, Brett M Stevens, John M Ashton, Jason R Myers, Kristen M O'Dwyer, Jane L Liesveld, Jason H Mendler, Monica Guzman, Jennifer D Morrissette, Jianhua Zhao, Eunice S Wang, Meir Wetzler, Craig T Jordan, Michael W Becker
Evolution of acute myelogenous leukemia stem cell properties after treatment and progression. Blood 128 (13) (2016)